![]() |
市場調查報告書
商品編碼
1829256
2025年全球泌尿系統醫療雷射市場報告Urology Medical Lasers Global Market Report 2025 |
近年來,泌尿系統醫用雷射市場規模穩定成長,從2024年的10.3億美元增加到2025年的10.6億美元,複合年成長率為3.2%。預測期內的成長可歸因於科技的快速進步、醫療支出的不斷成長、老年人口的快速成長、公共醫療保險改革以及新興市場的強勁經濟成長。
預計未來幾年泌尿系統醫用雷射市場將強勁成長,到2029年將達到13.3億美元,年複合成長率(CAGR)為5.9%。預測期內的成長將受到併購活動增加、研發和創新力度加大以及政府舉措的推動。預測期內的主要趨勢包括新技術的湧現、巨量資料和人工智慧的應用、針對良性前列腺增生的創新雷射治療以及光纖在雷射技術中的應用。
泌尿系統醫用雷射是泌尿系統的專用儀器,用於針對泌尿道、膀胱、腎臟、前列腺和其他相關器官進行一系列微創手術和治療。這些雷射透過發射集中的光束來精確切割、汽化或碎裂組織。使用這些雷射器的好處是減少出血、加快恢復速度,並最大程度地減少對周圍組織的損傷。
泌尿系統醫療雷射市場由各種類型的雷射組成,包括鈥雷射系統、二極體雷射系統和铥雷射系統。鈥雷射系統用於透過雷射手術去除結石,尤其是位於膀胱、腎臟、輸尿管和尿道的結石。這些雷射的應用範圍也擴展到治療良性前列腺增生 (BPH)、尿道結石和非肌肉層浸潤性膀胱癌 (NMIBC)。泌尿系統醫療雷射的主要終端使用者包括醫院、診所和其他醫療機構。
2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供泌尿系統醫療雷射器市場統計數據,例如全球市場規模、區域佔有率、競爭對手的泌尿系統醫療雷射器市場佔有率、詳細的泌尿系統醫療雷射器細分泌尿系統、市場趨勢和商機,以及您在泌尿系統醫療雷射器行業取得成功所需的數據。本泌尿系統醫療雷射器市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
我們預測未來五年市場將成長5.9%,較先前預測略有下降0.4%。下降的主要原因是美國與其他國家之間關稅的影響。這可能會直接影響美國,導致來自俄羅斯和新加坡等主要地區的铥雷射晶體和光纖傳輸系統供應鏈中斷,這可能導致前列腺治療技術供應減少。此外,由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這種影響也將更加廣泛地顯現。
泌尿系統疾病的發生率不斷上升是推動泌尿系統醫療雷射市場需求的關鍵因素。包括膀胱癌和前列腺疾病在內的泌尿系統病例的增加,推動了對微創手術及相關設備的需求。根據美國癌症研究所的統計數據,膀胱癌是男性第六常見癌症,女性第十七大常見癌症。泌尿系統疾病和病症的激增刺激了泌尿系統手術的需求,並支持了泌尿系統醫療雷射市場的成長。
泌尿系統疾病的持續上升預計將進一步推動泌尿系統醫療雷射市場的發展。泌尿器官系統疾病涵蓋影響男性和女性生殖和泌尿系統的各種問題。常見的泌尿系統疾病包括腎結石、尿道感染、膀胱控制問題和攝護腺問題。泌尿系統利用泌尿系統領域的雷射設備透過各種程序診斷和治療這些疾病。例如,美國癌症協會的《2023 年癌症事實與數據》報告顯示,2023 年美國將新增約 82,290 例膀胱癌病例,並有 16,710 例死於膀胱癌。此外,美國疾病管制與預防中心報告稱,2021 年美國約有 24,710 例導管相關尿道感染病例。泌尿系統疾病發生率的上升是泌尿系統醫療雷射市場的主要驅動力。
產品創新是泌尿系統醫療雷射市場日益流行的關鍵趨勢。產品創新有助於泌尿系統獲得更佳療效,提供診斷、治療和微創手術,進而改善臨床療效、降低整體成本並提升患者的生活品質。例如,2022年11月,印度阿波羅醫院推出了首台Moses 2.0雷射治療儀,這是一項先進的雷射技術,用於無血無痛治療高風險患者的大腎結石和前列腺肥大。 Moses 2.0雷射治療儀採用內視鏡操作,無需在皮膚上做切口。任何大小的腎結石和前列腺都可以完全治癒。
泌尿系統醫療雷射市場的主要企業正專注於開發先進技術產品,例如铥光纖雷射 (TFL) 系統,以實現卓越的精度、最大限度地減少組織損傷、提高結石破碎效率並提高安全性。铥光纖雷射 (TFL) 系統是一種高精度醫療雷射技術,主要用於泌尿系統的微創手術,例如腎結石破碎和前列腺組織切除,與傳統雷射系統相比,具有更高的安全性和效率。例如,2023 年 2 月,中國泌尿系統雷射器製造商萊茵雷射科技推出了 UroFiber 150Q。這款 150W 超脈衝铥光纖雷射 (TFL) 系統採用創新的全光纖技術,專為最佳結石破碎和 BPH 摘除而設計。它採用客製化的高亮度、窄頻譜、光纖耦合 792nm 二極體雷射來泵浦铥光纖,產生強大的 1940nm CW/QCW 雷射光束。在超脈衝模式(QCW)下,其最大雷射重複頻率可達5000Hz,峰值功率可達600W,平均功率可達150W,最小脈衝能量可達0.025J。此外,在脈衝模式下,其脈衝能量在25Hz下可達6J;在連續模式(CW)下,其功率可達150W,可實現7天24小時高效運行,噪音水平低於60dB,完全符合業界標準。
2024年2月,美國醫療設備製造商OmniGuide Holdings (OGH) 將與UROTECH達成夥伴關係,以增強UROTECH的泌尿系統技術組合。此次合作將建立一個以RevoLix™ HTL(混合铥雷射療法)為中心的全球網路,並與泌尿系統密切合作,特別專注於推進腎結石和良性前列腺增生 (BPH) 的治療方法。 UROTECH是一家總部位於德國的醫療技術公司,專注於泌尿系統領域。
泌尿系統醫療雷射市場的主要公司包括Olympus Corporation、波士頓科學公司、科醫人有限公司、理查德·沃爾夫有限公司、廣達系統公司、史賽克公司、OmniGuide Holdings Inc.、Convergent Laser Technologies、Biolitec AG、Allengers Medical Systems Limited、常州美迪泰克貿易有限公司、蘇州工業社科、醫學. Ltd.、Anatomics、SignatureOrtho、Fresenius Medical Care AG &Co、KARL STORZ、EndoMed Systems GmbH、Dornier MedTech、Braun Melsungen AG、Lisa Laser、IRE-Polus、IPG Photonics Co、Capital Clinic Riga 和 Aertzio、IRE-Polus、IPG Photonics Co、Capital Clinic Riga 和 Aertzio、IRE-Polus、IPG Photonics Co、Capital Clinic Riga 及加拿大 Mertzio、IRE 醫療中心、莫斯科私人診所、Clina Tambre、立體定位放射線手術中心「Sigulda」、Cook Medical、CR Bard、Healthtronics、Surgical Laser、Medtronic、AeroLase、Cutera、Synojar、 Medtronic、Sharplight Technologies、Syneron Medical、Solta Medical、Alma Laser、Euracare。
2024年泌尿系統醫療雷射市場最大的地區是北美。亞太地區是泌尿系統醫療雷射報告涵蓋的第二大地區。泌尿系統醫療雷射器市場報告涵蓋以下地區:亞太地區、西歐、東歐、北美、南美、中東和非洲。
泌尿系統醫療雷射市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、義大利、加拿大和西班牙。
泌尿系統醫療雷射市場涵蓋鈥雷射系統、二極體雷射系統、铥雷射系統等產品的銷售。該市場的商品價值為出廠價,即商品製造商或生產商向其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接向最終客戶銷售的商品價值。該市場的商品價值還包括商品製造商提供的任何相關服務。
Urology medical lasers are specialized instruments utilized in urology to conduct a range of minimally invasive surgeries and treatments targeting the urinary tract, bladder, kidneys, prostate, and other related organs. These lasers function by emitting concentrated beams of light energy to accurately cut, vaporize, or fragment tissue. The benefits of using these lasers include reduced bleeding, quicker recovery times, and minimal harm to surrounding tissues.
The urology medical lasers market encompasses various types, with notable examples being the holmium laser system, diode laser system, thulium laser system, and others. Holmium laser systems are specifically employed for the removal of stones in the bladder, kidneys, ureters, or urethra through laser-based procedures. The applications of these lasers extend to treating conditions such as benign prostatic hyperplasia (BPH), urolithiasis, non-muscle-invasive bladder cancer (NMIBC), and others. The primary end-users of urology medical lasers include hospitals, clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The urology medical lasers market research report is one of a series of new reports from The Business Research Company that provides urology medical lasers market statistics, including urology medical lasers industry global market size, regional shares, competitors with a urology medical lasers market share, detailed urology medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the urology medical lasers industry. This urology medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The urology medical lasers market size has grown steadily in recent years. It will grow from $1.03 billion in 2024 to $1.06 billion in 2025 at a compound annual growth rate (CAGR) of 3.2%. The growth in the historic period can be attributed to rapid technological advances, increased healthcare expenditure, rapid growth in elderly population, public health insurance reforms and strong economic growth in emerging markets.
The urology medical lasers market size is expected to see strong growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to an increase in mergers and acquisitions, an increase in R&D and innovations, and government initiatives will drive the growth. Major trends in the forecast period include emergence of novel technologies, use of big data and artificial intelligence, innovative laser treatments for benign prostatic hyperplasia, and use of fiber-optics in laser technology.
The forecast of 5.9% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for thulium laser crystals and fiber-optic delivery systems, sourced from key regions such as Russia and Singapore, could lead to reduced availability of prostate treatment technologies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of urological disorders is a significant factor driving the demand for the urology medical lasers market. A rise in urological cases, including conditions such as bladder cancer and prostate diseases, is fostering the need for minimally invasive surgeries and associated devices. According to statistics from the American Institute for Cancer Research, bladder cancer ranks as the sixth most common cancer in men and the 17th most common cancer in women. This upsurge in urological diseases and conditions is fueling the demand for urological surgeries, thereby supporting the growth of the urology medical lasers market.
The continued growth in the incidence of urologic conditions is anticipated to propel the urology medical lasers market further. Urologic conditions encompass a range of issues affecting the reproductive or urinary tract systems in both males and females. Common urologic diseases include kidney stones, urinary tract infections, bladder control problems, and prostate issues. Urologists utilize laser instruments in the field of urology to diagnose and treat these conditions through various procedures. For instance, the American Cancer Society's Cancer Facts and Figures 2023 report reveals approximately 82,290 new cases of bladder cancer and 16,710 deaths from bladder cancer in the United States in 2023. Additionally, in 2021, the Centers for Disease Control and Prevention reported around 24,710 catheter-associated urinary tract infections in the U.S. The rising incidence of urologic conditions is a key driver for the urology medical lasers market.
Product innovation is a key trend gaining popularity in the urology medical lasers market. The product innovations assist urologists in achieving better outcomes and deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. For instance, in November 2022, Apollo, an India-based hospital launched first Moses 2.0, an advanced laser technology to treat large kidney stones and prostate enlargement on high-risk patients in a bloodless and painless manner. Procedures conducted with Moses 2.0 are endoscopic and do not involve cutting open of the skin. Any size of kidney stones and the prostate can be completely treated.
Leading companies in the urology medical lasers market are focusing on developing advanced technological products, such as thulium fiber laser (TFL) systems, to deliver superior precision, minimize tissue damage, enhance stone fragmentation efficiency, and improve safety. The thulium fiber laser (TFL) system represents a high-precision medical laser technology primarily employed in urology for minimally invasive procedures, including kidney stone fragmentation and prostate tissue removal, offering greater safety and efficiency compared to traditional laser systems. For example, in February 2023, Rhein Laser Technologies Ltd., a China-based manufacturer of urology lasers, launched the UroFiber 150Q. This 150W SuperPulsed thulium fiber laser (TFL) system features innovative all-fiber technology specifically designed for optimal stone lithotripsy and BPH enucleation. It employs a customized high-brightness narrow spectrum fiber-coupling 792nm diode laser to pump the thulium fiber, producing a powerful 1940nm CW&QCW laser. In SuperPulsed mode (QCW), it can achieve a peak power of 600W, with an average output of 150W and a maximum laser repetition rate of 5000Hz at a minimum pulse energy of 0.025J. Furthermore, it can reach up to 6J pulse energy at 25Hz in pulsed mode and maintain 150W in continuous mode (CW), operating efficiently 24/7 with noise levels below 60dB, fully compliant with industry standards.
In February 2024, OmniGuide Holdings (OGH), a US-based medical device company, entered into a partnership with UROTECH to enhance UROTECH's urology technology portfolio. This collaboration will work closely with urologists to establish a global network centered around RevoLix(TM) HTL (Hybrid Thulium Laser Therapy), focusing specifically on advancing treatments for kidney stones and benign prostatic hyperplasia (BPH). UROTECH is a Germany-based medical technology company specializing in urology.
Major companies operating in the urology medical lasers market include Olympus Corporation, Boston Scientific Corporation, Lumenis Ltd., Richard Wolf GmbH, Quanta System S.p.A., Stryker Corporation, OmniGuide Holdings Inc., Convergent Laser Technologies, Biolitec AG, Allengers Medical Systems Limited, Changzhou Meditech Trading Co. Ltd, Shuzhou Sunan Zimmered Medical Instrument Co. LTD, Narang Medical Limited, Atlas Surgical, Auxein Medical, Seikagaku Corporation, Anatomics, SignatureOrtho, Fresenius Medical Care AG & Co, KARL STORZ, EndoMed Systems GmbH, Dornier MedTech, Braun Melsungen AG, Lisa Laser, IRE-Polus, IPG Photonics Co, Capital Clinic Riga, Nick Mertziotis MDPh.D, Moscow Next Generation Clinic, Private Gurlife Hospital, Warsaw Surgery Clinic, Laser Med Medical Centre, Clinica Tambre, Stereotactic Radiosurgery Center 'SIGULDA', Cook Medical Incorporated, CR Bard, Healthtronics Inc, Surgical Lasers Inc, Medtronic, Aerolase, cutera, Cynosure inc, Sciton inc, Sharplight Technologies, Syneron Medical inc, SoltaMedical inc, Alma Lasers, Euracare.
North America was the largest region in the urology medical lasers market in 2024. Asia-Pacific was the second largest region in the urology medical lasers report. The regions covered in the urology medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the urology medical lasers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The urology medical lasers market consists of sales of holmium laser system, diode laser system, thulium laser system, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Urology Medical Lasers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on urology medical lasers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for urology medical lasers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urology medical lasers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.